ArticleTranslational lung cancer research2025

Long-term efficacy and improved overall survival of lorlatinib in anaplastic lymphoma kinase-rearranged lung cancer: is cure a dream or a reality?

Yoshitsugu Horio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.